Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
May 0510:00 AM PDT
-11:00 AM PDT
GMAT Inequalities is a high-frequency topic in GMAT Quant, but many students struggle because the concepts behave differently from standard algebra. Understanding the right rules, patterns, and edge cases can significantly improve both speed and accuracy.- May 06
08:30 AM PDT
-09:30 AM PDT
In Episode 3 of our GMAT Ninja Critical Reasoning series, we tackle Discrepancy, Paradox, and Explain an Oddity questions. You know the feeling: the passage gives you two facts that seem completely contradictory.... - May 08
08:00 AM PDT
-08:30 AM PDT
Join the special YouTube live-stream for selecting the winners of GMAT Club MBA Scholarships sponsored by Juno live. Watch who gets these coveted MBA scholarships offered by GMAT Club and Juno.
03 May 2026, 03:15
Kudos
Bookmarks
C
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
(N/A)
Question Stats:
90% (01:25) correct
10%
(01:40)
wrong
based on 10
sessions
History
Date
Time
Result
Not Attempted Yet
Nanotechnology is a field of research that involves manipulating materials at the atomic or molecular level to achieve remarkable properties and functionalities. Recently, it has been discovered that certain nanoparticles used in consumer products can accumulate in the human body and cause adverse health effects. Supporters of nanotechnology argue that these concerns are overblown and that the benefits of nanotechnology, such as improved drug delivery and environmental cleanup, far outweigh the risks.
Which of the following, if true, most strengthens the argument of the supporters of nanotechnology?
A) The majority of nanoparticles used in consumer products do not have the ability to penetrate human skin.
B) Recent studies have shown that the accumulation of nanoparticles in the body can be effectively monitored and regulated.
C) The health benefits of drug delivery systems using nanotechnology have significantly improved patient outcomes in clinical trials.
D) Fewer adverse health effects have been reported in countries that have implemented strict regulations on the use of nanoparticles.
E) Advances in nanotechnology are projected to reduce the cost of manufacturing environmentally friendly products in the next decade.
Which of the following, if true, most strengthens the argument of the supporters of nanotechnology?
A) The majority of nanoparticles used in consumer products do not have the ability to penetrate human skin.
B) Recent studies have shown that the accumulation of nanoparticles in the body can be effectively monitored and regulated.
C) The health benefits of drug delivery systems using nanotechnology have significantly improved patient outcomes in clinical trials.
D) Fewer adverse health effects have been reported in countries that have implemented strict regulations on the use of nanoparticles.
E) Advances in nanotechnology are projected to reduce the cost of manufacturing environmentally friendly products in the next decade.
03 May 2026, 05:59
Kudos
Bookmarks
Argument: Supporters claim that the benefits of nanotechnology outweigh its health risks.
Evaluate choices:
A: Only limits one exposure route, weak.
B: Monitoring doesn’t show risks are small or benefits larger, weak.
C: Shows strong, proven health benefits, directly supports benefits outweigh risks.
D: Suggests regulation helps but doesn’t compare benefits vs risks, indirect.
E: Cost reduction not relevant to health risk comparison.
Answer: C
Evaluate choices:
A: Only limits one exposure route, weak.
B: Monitoring doesn’t show risks are small or benefits larger, weak.
C: Shows strong, proven health benefits, directly supports benefits outweigh risks.
D: Suggests regulation helps but doesn’t compare benefits vs risks, indirect.
E: Cost reduction not relevant to health risk comparison.
Answer: C
03 May 2026, 09:00
Kudos
Bookmarks
Nanotechnology is a field of research that involves manipulating materials at the atomic or molecular level to achieve remarkable properties and functionalities. Recently, it has been discovered that certain nanoparticles used in consumer products can accumulate in the human body and cause adverse health effects. Supporters of nanotechnology argue that these concerns are overblown and that the benefits of nanotechnology, such as improved drug delivery and environmental cleanup, far outweigh the risks.
Which of the following, if true, most strengthens the argument of the supporters of nanotechnology?
The supporters argue that the risks of nanotechnology are overstated and that the benefits are greater than the risks. The best strengthener should show that nanotechnology produces major real benefits, especially benefits strong enough to outweigh possible health concerns.
(A) The majority of nanoparticles used in consumer products do not have the ability to penetrate human skin.
This helps a little because it reduces one possible risk. But the concern is about nanoparticles accumulating in the human body, and this answer addresses only skin penetration.
(B) Recent studies have shown that the accumulation of nanoparticles in the body can be effectively monitored and regulated.
This helps by showing that the risk can be controlled. But it does not directly show that the benefits outweigh the risks.
(C) The health benefits of drug delivery systems using nanotechnology have significantly improved patient outcomes in clinical trials.
This is correct. It gives direct evidence that nanotechnology has produced significant medical benefits. That strongly supports the claim that its benefits can outweigh its risks.
(D) Fewer adverse health effects have been reported in countries that have implemented strict regulations on the use of nanoparticles.
This shows that regulation may reduce harm, but it does not directly support the broader claim that nanotechnology’s benefits outweigh its risks.
(E) Advances in nanotechnology are projected to reduce the cost of manufacturing environmentally friendly products in the next decade.
This gives a possible future benefit, but it is only a projection and is less direct than actual improved patient outcomes.
Answer: (C)
Which of the following, if true, most strengthens the argument of the supporters of nanotechnology?
The supporters argue that the risks of nanotechnology are overstated and that the benefits are greater than the risks. The best strengthener should show that nanotechnology produces major real benefits, especially benefits strong enough to outweigh possible health concerns.
(A) The majority of nanoparticles used in consumer products do not have the ability to penetrate human skin.
This helps a little because it reduces one possible risk. But the concern is about nanoparticles accumulating in the human body, and this answer addresses only skin penetration.
(B) Recent studies have shown that the accumulation of nanoparticles in the body can be effectively monitored and regulated.
This helps by showing that the risk can be controlled. But it does not directly show that the benefits outweigh the risks.
(C) The health benefits of drug delivery systems using nanotechnology have significantly improved patient outcomes in clinical trials.
This is correct. It gives direct evidence that nanotechnology has produced significant medical benefits. That strongly supports the claim that its benefits can outweigh its risks.
(D) Fewer adverse health effects have been reported in countries that have implemented strict regulations on the use of nanoparticles.
This shows that regulation may reduce harm, but it does not directly support the broader claim that nanotechnology’s benefits outweigh its risks.
(E) Advances in nanotechnology are projected to reduce the cost of manufacturing environmentally friendly products in the next decade.
This gives a possible future benefit, but it is only a projection and is less direct than actual improved patient outcomes.
Answer: (C)
